Application of Biomaterials in the Treatment of Cardiovascular Diseases

This book summarizes the recent advancements for biomaterials in the field of cardiovascular disease, including drug delivery system (gene, protein, drug), implant interventional instrument (heart valve, heart blocker, stent, artificial blood vessel, patch, artificial heart, cardiac pacemaker, etc.) have been innovated and applied to the clinical uses to treatment of cardiovascular disease. Through the summary of this book, readers will have comprehensive and advanced understanding of the application of biomaterials in the field of cardiovascular disease.

Dr. Yi-da Tang is a Professor at Department of Cardiology , Peking University Third Hospital, Beijing, China. Yida Tang, MD, PhD, director of  the cardiology department of Peking University Third Hospital, Deputy Director of key laboratory of Molecular Cardiology of Peking University Health Science Center.  Winner of the National Science Foundation for Distinguished Young Scholars, distinguished professor of Yangtze River scholars of the Ministry of Education, young and middle-aged experts with outstanding contributions of the national million talents project, and Leading talents of capital science and technology. His society membership mainly includes the leader of metabolic cardiovascular disease group of Chinese Society Cardiology, the president of Beijing Association of precision medicine, fellow of the American College of Cardiology (FACC), fellow of the European Society of Cardiology (FESC), fellow of the Society for Cardiovascular Angiography and Interventions (FSCAI).

 Dr. Jing Yang is a Professor at Institute of Biomedical Engineering, Chinese Academy of Medical Science and Peking Union Medical College. She is doctoral supervisor of Biomedical Engineering and Pharmacy of Peking Union Medical College.  She received Ph.D from Peking Union Medical College. Her research interests include the design of  biomaterials and drug delivery system and their application in the treatment of cardiovascular diseases.

Dr. Yongjun Li is chief of Department of Vascular Surgery, Beijing Hospital, National Centre of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences; He is a Professor of Peking Union Medical College and Peking University. He received his M.D at Sun Yet-san University of Medical Sciences and PhD. in Peking Union Medical College. He is Chairman of Chinese Medical Education Association Peripheral Vascular Disease Committee and a member of Chinese Medical Association Vascular Surgeon committee, a member of Chinese Medical Doctor Association Vascular Surgeon Committee and Deputy Secretary-General of National Society of Vascular Surgery. His lab mainly focuses on treatment and translational studies of vasculardiseases.

Dr. Yong Zeng  is the director of the Department of Cardiology at Beijing Anzhen Hospital, Capital Medical University. He received Master's degree from West China University of Medical Sciences and M.D. from Peking Union Medical College. He is an ESC Fellow, a member of the Cardiac Critical Care Expert Committee of the Cross-Strait Medical and Health Exchange Association, and a China Member of the Atherosclerosis and Coronary Heart Disease Group of the Cardiovascular Branch of the Medical Association. Dr. Zeng was one of the first instructors in the Cardiovascular Interventional Diagnosis and Treatment Training Base of the Ministry of Health (Coronary Heart Disease Intervention), was part of the editorial board of the Chin J Cardiology, the Chinese Preventive Medicine, and was a reviewer of Chinese Diabetes and other journals.